Reader Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging
Uložené v:
| Názov: | Reader Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging |
|---|---|
| Autori: | Paolo Salvioni Chiabotti, Olivier Rouaud, Gilles Allali |
| Zdroj: | Neurology, vol. 102, no. 9, pp. e209375 |
| Informácie o vydavateľovi: | Ovid Technologies (Wolters Kluwer Health), 2024. |
| Rok vydania: | 2024 |
| Predmety: | Amyloid beta-Peptides, Cognitive Aging, Alzheimer Disease, Humans, Cognitive Aging/physiology, Alzheimer Disease/drug therapy, Aged |
| Druh dokumentu: | Article |
| Popis súboru: | application/pdf |
| Jazyk: | English |
| ISSN: | 1526-632X 0028-3878 |
| DOI: | 10.1212/wnl.0000000000209375 |
| Prístupová URL adresa: | https://pubmed.ncbi.nlm.nih.gov/38648577 http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_610FAABF4BED5 https://serval.unil.ch/notice/serval:BIB_610FAABF4BED https://serval.unil.ch/resource/serval:BIB_610FAABF4BED.P001/REF.pdf |
| Prístupové číslo: | edsair.doi.dedup.....2cb6fdb53e7be5c45162fa1ea22c5257 |
| Databáza: | OpenAIRE |
Full Text Finder 
Nájsť tento článok vo Web of Science | ISSN: | 1526632X 00283878 |
|---|---|
| DOI: | 10.1212/wnl.0000000000209375 |